Mycobacterium fortuitum

Jump to: navigation, search
Mycobacterium fortuitum
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. fortuitum
Binomial name
Mycobacterium fortuitum
Da Costa Cruz 1938, ATCC 6841

WikiDoc Resources for Mycobacterium fortuitum

Articles

Most recent articles on Mycobacterium fortuitum

Most cited articles on Mycobacterium fortuitum

Review articles on Mycobacterium fortuitum

Articles on Mycobacterium fortuitum in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mycobacterium fortuitum

Images of Mycobacterium fortuitum

Photos of Mycobacterium fortuitum

Podcasts & MP3s on Mycobacterium fortuitum

Videos on Mycobacterium fortuitum

Evidence Based Medicine

Cochrane Collaboration on Mycobacterium fortuitum

Bandolier on Mycobacterium fortuitum

TRIP on Mycobacterium fortuitum

Clinical Trials

Ongoing Trials on Mycobacterium fortuitum at Clinical Trials.gov

Trial results on Mycobacterium fortuitum

Clinical Trials on Mycobacterium fortuitum at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mycobacterium fortuitum

NICE Guidance on Mycobacterium fortuitum

NHS PRODIGY Guidance

FDA on Mycobacterium fortuitum

CDC on Mycobacterium fortuitum

Books

Books on Mycobacterium fortuitum

News

Mycobacterium fortuitum in the news

Be alerted to news on Mycobacterium fortuitum

News trends on Mycobacterium fortuitum

Commentary

Blogs on Mycobacterium fortuitum

Definitions

Definitions of Mycobacterium fortuitum

Patient Resources / Community

Patient resources on Mycobacterium fortuitum

Discussion groups on Mycobacterium fortuitum

Patient Handouts on Mycobacterium fortuitum

Directions to Hospitals Treating Mycobacterium fortuitum

Risk calculators and risk factors for Mycobacterium fortuitum

Healthcare Provider Resources

Symptoms of Mycobacterium fortuitum

Causes & Risk Factors for Mycobacterium fortuitum

Diagnostic studies for Mycobacterium fortuitum

Treatment of Mycobacterium fortuitum

Continuing Medical Education (CME)

CME Programs on Mycobacterium fortuitum

International

Mycobacterium fortuitum en Espanol

Mycobacterium fortuitum en Francais

Business

Mycobacterium fortuitum in the Marketplace

Patents on Mycobacterium fortuitum

Experimental / Informatics

List of terms related to Mycobacterium fortuitum

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mycobacterium fortuitum

Description

Gram-positive, nonmotile and acid-fast rods (1-3µm x 0.2-0.4µm). Sometimes long rods with occasional beaded or swollen cells having non-acid-fast ovoid bodies at one end.

Colony characteristics

  • Smooth hemispheric colonies, usually off-white or cream colored colonies. May be butyrous, waxy, multilobate and even rosette clustered (dilute inocula).
  • On Malachite green containing media, such as Löwenstein-Jensen media, colonies can absorb the green dye.

Physiology

  • Rapid growth on Löwenstein-Jensen media within 2-4 days.
  • No growth at 45°C, but grows on MacConkey agar

Differential characteristics

  • Differentiation from M. fortuitum subsp. acetamidolyticum by its ability to utilise L-glutamate and its inability to utilise acetamide as simultaneous nitrogen and carbon source. Both subspecies share an identical 5'-16S rDNA sequence. However, the ITS sequences are different.

Pathogenesis

  • Different types of sporadic infections: pulmonary disease, local abscesses.
  • Postoperative sternal wound infections, endocarditis, meningitis, and osteomyelitis.
  • Has produced postoperative infections after breast augmentation surgury.
  • Biosafety level 2

Type Strain

  • Found world wide in soil, dust, rivers, lakes and tap water.
  • First isolated from a 25-year old patient (syringe abscess) in Rio de Janeiro.
  • Also isolated from lymph glands of cattle and systemic or nodular infection of frogs.

Strain ATCC 6841 = CCUG 20994 = CIP 104534 = DSM 46621 = IFO (now NBRC) 13159 = JCM 6387 = NCTC 10394.

Subsequently, this species has been divided into subspecies M. fortuitum subsp. acetamidolyticum

References

  • Da Costa Cruz, J. 1938. Mycobacterium fortuitum um novo bacillo acidoresistance pathogenico para o homen. Acta Medica (Rio de Janeiro), 1, 297-301.]


de:Mycobacterium fortuitum nl:Mycobacterium fortuitum

Cost Effectiveness of Mycobacterium fortuitum

| group5 = Clinical Trials Involving Mycobacterium fortuitum | list5 = Ongoing Trials on Mycobacterium fortuitum at Clinical Trials.govTrial results on Mycobacterium fortuitumClinical Trials on Mycobacterium fortuitum at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Mycobacterium fortuitum | list6 = US National Guidelines Clearinghouse on Mycobacterium fortuitumNICE Guidance on Mycobacterium fortuitumNHS PRODIGY GuidanceFDA on Mycobacterium fortuitumCDC on Mycobacterium fortuitum


| group7 = Textbook Information on Mycobacterium fortuitum | list7 = Books and Textbook Information on Mycobacterium fortuitum


| group8 = Pharmacology Resources on Mycobacterium fortuitum | list8 = AND (Dose)}} Dosing of Mycobacterium fortuitumAND (drug interactions)}} Drug interactions with Mycobacterium fortuitumAND (side effects)}} Side effects of Mycobacterium fortuitumAND (Allergy)}} Allergic reactions to Mycobacterium fortuitumAND (overdose)}} Overdose information on Mycobacterium fortuitumAND (carcinogenicity)}} Carcinogenicity information on Mycobacterium fortuitumAND (pregnancy)}} Mycobacterium fortuitum in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Mycobacterium fortuitum


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Mycobacterium fortuitum | list9 = AND (pharmacogenomics)}} Genetics of Mycobacterium fortuitumAND (pharmacogenomics)}} Pharmacogenomics of Mycobacterium fortuitumAND (proteomics)}} Proteomics of Mycobacterium fortuitum


| group10 = Newstories on Mycobacterium fortuitum | list10 = Mycobacterium fortuitum in the newsBe alerted to news on Mycobacterium fortuitumNews trends on Mycobacterium fortuitum


| group11 = Commentary on Mycobacterium fortuitum | list11 = Blogs on Mycobacterium fortuitum

| group12 = Patient Resources on Mycobacterium fortuitum | list12 = Patient resources on Mycobacterium fortuitumDiscussion groups on Mycobacterium fortuitumPatient Handouts on Mycobacterium fortuitumDirections to Hospitals Treating Mycobacterium fortuitumRisk calculators and risk factors for Mycobacterium fortuitum


| group13 = Healthcare Provider Resources on Mycobacterium fortuitum | list13 = Symptoms of Mycobacterium fortuitumCauses & Risk Factors for Mycobacterium fortuitumDiagnostic studies for Mycobacterium fortuitumTreatment of Mycobacterium fortuitum

| group14 = Continuing Medical Education (CME) Programs on Mycobacterium fortuitum | list14 = CME Programs on Mycobacterium fortuitum

| group15 = International Resources on Mycobacterium fortuitum | list15 = Mycobacterium fortuitum en EspanolMycobacterium fortuitum en Francais

| group16 = Business Resources on Mycobacterium fortuitum | list16 = Mycobacterium fortuitum in the MarketplacePatents on Mycobacterium fortuitum

| group17 = Informatics Resources on Mycobacterium fortuitum | list17 = List of terms related to Mycobacterium fortuitum


}}



Linked-in.jpg